vs
BATTALION OIL CORP(BATL)与STANDARD BIOTOOLS INC.(LAB)财务数据对比。点击上方公司名可切换其他公司
BATTALION OIL CORP的季度营收约是STANDARD BIOTOOLS INC.的1.6倍($31.6M vs $19.6M),BATTALION OIL CORP净利率更高(5.7% vs -177.4%,领先183.1%),STANDARD BIOTOOLS INC.同比增速更快(-11.5% vs -36.1%),过去两年STANDARD BIOTOOLS INC.的营收复合增速更高(-12.2% vs -20.1%)
巴塔利昂石油公司是一家独立能源企业,核心业务为原油、天然气及天然气凝析液的勘探、开发与生产,主要运营资产位于美国得克萨斯州南部的伊格尔福特页岩区,服务北美能源市场的商业及工业客户。
Standard BioTools(原Fluidigm公司)是一家美国生命科学工具企业,主营流式细胞术与组织成像分析用质谱流式系统,以及配套的检测试剂盒与试剂,同时供应自动化基因组分析仪器、各类微流控芯片(又称集成流体电路)及配套试剂耗材,全系列产品及应用场景均可提供定制检测方案与相关服务。
BATL vs LAB — 直观对比
营收规模更大
BATL
是对方的1.6倍
$19.6M
营收增速更快
LAB
高出24.7%
-36.1%
净利率更高
BATL
高出183.1%
-177.4%
两年增速更快
LAB
近两年复合增速
-20.1%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $31.6M | $19.6M |
| 净利润 | $1.8M | $-34.7M |
| 毛利率 | — | 48.5% |
| 营业利润率 | -33.8% | -168.5% |
| 净利率 | 5.7% | -177.4% |
| 营收同比 | -36.1% | -11.5% |
| 净利润同比 | 108.1% | -28.8% |
| 每股收益(稀释后) | $-0.77 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
BATL
LAB
| Q4 25 | $31.6M | — | ||
| Q3 25 | $43.4M | $19.6M | ||
| Q2 25 | $42.6M | $21.8M | ||
| Q1 25 | $47.4M | $40.8M | ||
| Q4 24 | $49.5M | — | ||
| Q3 24 | $45.1M | $22.1M | ||
| Q2 24 | $49.1M | $22.5M | ||
| Q1 24 | $49.5M | $45.5M |
净利润
BATL
LAB
| Q4 25 | $1.8M | — | ||
| Q3 25 | $-735.0K | $-34.7M | ||
| Q2 25 | $4.8M | $-33.5M | ||
| Q1 25 | $6.0M | $-26.0M | ||
| Q4 24 | $-22.2M | — | ||
| Q3 24 | $21.6M | $-26.9M | ||
| Q2 24 | $-105.0K | $-45.7M | ||
| Q1 24 | $-31.2M | $-32.2M |
毛利率
BATL
LAB
| Q4 25 | — | — | ||
| Q3 25 | — | 48.5% | ||
| Q2 25 | — | 48.8% | ||
| Q1 25 | — | 48.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 54.9% | ||
| Q2 24 | — | 46.1% | ||
| Q1 24 | — | 53.1% |
营业利润率
BATL
LAB
| Q4 25 | -33.8% | — | ||
| Q3 25 | 1.9% | -168.5% | ||
| Q2 25 | -0.4% | -118.1% | ||
| Q1 25 | 7.2% | -80.8% | ||
| Q4 24 | -36.2% | — | ||
| Q3 24 | 2.3% | -120.9% | ||
| Q2 24 | 10.4% | -134.5% | ||
| Q1 24 | 0.0% | -132.2% |
净利率
BATL
LAB
| Q4 25 | 5.7% | — | ||
| Q3 25 | -1.7% | -177.4% | ||
| Q2 25 | 11.3% | -153.7% | ||
| Q1 25 | 12.7% | -63.8% | ||
| Q4 24 | -44.9% | — | ||
| Q3 24 | 48.0% | -122.0% | ||
| Q2 24 | -0.2% | -203.3% | ||
| Q1 24 | -63.0% | -70.6% |
每股收益(稀释后)
BATL
LAB
| Q4 25 | $-0.77 | — | ||
| Q3 25 | $-0.91 | $-0.09 | ||
| Q2 25 | $-0.21 | $-0.09 | ||
| Q1 25 | $-0.35 | $-0.07 | ||
| Q4 24 | $-1.47 | — | ||
| Q3 24 | $0.34 | $-0.07 | ||
| Q2 24 | $-0.53 | $-0.12 | ||
| Q1 24 | $-2.24 | $-0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $28.0M | $129.4M |
| 总债务越低越好 | $208.1M | — |
| 股东权益账面价值 | $-32.8M | $399.7M |
| 总资产 | $460.7M | $539.6M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
BATL
LAB
| Q4 25 | $28.0M | — | ||
| Q3 25 | $50.5M | $129.4M | ||
| Q2 25 | $44.6M | $158.6M | ||
| Q1 25 | $73.6M | $150.9M | ||
| Q4 24 | $19.7M | — | ||
| Q3 24 | $29.8M | $210.6M | ||
| Q2 24 | $54.4M | $269.8M | ||
| Q1 24 | $48.9M | $287.1M |
总债务
BATL
LAB
| Q4 25 | $208.1M | — | ||
| Q3 25 | $213.8M | — | ||
| Q2 25 | $219.4M | — | ||
| Q1 25 | $225.1M | — | ||
| Q4 24 | $162.1M | — | ||
| Q3 24 | $147.8M | $55.2M | ||
| Q2 24 | $160.4M | $55.1M | ||
| Q1 24 | $190.2M | $55.0M |
股东权益
BATL
LAB
| Q4 25 | $-32.8M | — | ||
| Q3 25 | $-20.3M | $399.7M | ||
| Q2 25 | $-5.2M | $424.5M | ||
| Q1 25 | $-1.8M | $454.6M | ||
| Q4 24 | $4.1M | — | ||
| Q3 24 | $35.0M | $489.3M | ||
| Q2 24 | $22.7M | $510.3M | ||
| Q1 24 | $31.3M | $577.3M |
总资产
BATL
LAB
| Q4 25 | $460.7M | — | ||
| Q3 25 | $491.7M | $539.6M | ||
| Q2 25 | $498.8M | $557.0M | ||
| Q1 25 | $506.2M | $579.6M | ||
| Q4 24 | $431.0M | — | ||
| Q3 24 | $458.0M | $681.5M | ||
| Q2 24 | $487.3M | $708.7M | ||
| Q1 24 | $488.6M | $777.7M |
负债/权益比
BATL
LAB
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 39.35× | — | ||
| Q3 24 | 4.23× | 0.11× | ||
| Q2 24 | 7.07× | 0.11× | ||
| Q1 24 | 6.07× | 0.10× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $-11.8M | $-22.2M |
| 自由现金流经营现金流 - 资本支出 | — | $-23.1M |
| 自由现金流率自由现金流/营收 | — | -118.1% |
| 资本支出强度资本支出/营收 | — | 4.5% |
| 现金转化率经营现金流/净利润 | -6.58× | — |
| 过去12个月自由现金流最近4个季度 | — | $-111.1M |
8季度趋势,按日历期对齐
经营现金流
BATL
LAB
| Q4 25 | $-11.8M | — | ||
| Q3 25 | $28.0M | $-22.2M | ||
| Q2 25 | $10.2M | $-20.7M | ||
| Q1 25 | $12.7M | $-30.3M | ||
| Q4 24 | $6.7M | — | ||
| Q3 24 | $-5.1M | $-27.9M | ||
| Q2 24 | $29.8M | $-39.0M | ||
| Q1 24 | $3.9M | $-62.5M |
自由现金流
BATL
LAB
| Q4 25 | — | — | ||
| Q3 25 | — | $-23.1M | ||
| Q2 25 | — | $-22.6M | ||
| Q1 25 | — | $-35.3M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-30.1M | ||
| Q2 24 | — | $-41.0M | ||
| Q1 24 | — | $-63.3M |
自由现金流率
BATL
LAB
| Q4 25 | — | — | ||
| Q3 25 | — | -118.1% | ||
| Q2 25 | — | -103.6% | ||
| Q1 25 | — | -86.6% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -136.4% | ||
| Q2 24 | — | -182.2% | ||
| Q1 24 | — | -138.9% |
资本支出强度
BATL
LAB
| Q4 25 | — | — | ||
| Q3 25 | — | 4.5% | ||
| Q2 25 | — | 8.7% | ||
| Q1 25 | — | 12.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 10.2% | ||
| Q2 24 | — | 8.6% | ||
| Q1 24 | — | 1.7% |
现金转化率
BATL
LAB
| Q4 25 | -6.58× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 2.13× | — | ||
| Q1 25 | 2.11× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -0.23× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BATL
| Oil | $28.6M | 91% |
| Natural Gas Liquids Reserves | $3.9M | 12% |
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |